Top Banner
BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005
68

BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Dec 25, 2015

Download

Documents

Brittany Cobb
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

BIOLOGICAL TERRORISM

Edward L. Goodman, MD, Chief of Infectious Diseases

Presbyterian Hospital of Dallas

December 14, 2005

Page 2: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Biological Terrorism

Use of biological agents to intentionally produce disease or intoxication in susceptible populations to meet terrorist aims

Has been done in the past on a limited scale

U.S. must be prepared to respond to this threat

Page 3: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 4: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

History of Biological Warfare

In 1346, Tartar army hurled corpses of plague victims over the walls of Caffa, a seaport on the Crimean coast

In 1718, Russians used same tactic against Sweden

During the Pontiac Rebellion in 1763, the British army provided the Delaware Indians with blankets and handkerchiefs from the “Smallpox Hospital”

Page 5: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

History of Biological Warfare (cont.)

German program in WWI Japanese program in WWII In 1943, the U.S. began research into the

offensive use of biological agents: Program stopped by President Nixon in 1969

Page 6: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

History of Biological Warfare (cont.)

In 1972, U.S. and many other countries signed the Biological Weapons Convention

Former Soviet Union program began massive effort in 1970s

Today, term “warfare” is outdated…terrorism of civilian populations major risk: Anthrax in 12 persons 2001

Page 7: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Why There was a Belief Bioterrorism in the U.S. Would Not Happen

Biologic weapons seldom used Their use is morally repugnant to most Technologically difficult? Concept of “nuclear winter” was

“unthinkable” and thus dismissed until suicide hijackers and anthrax appeared

Page 8: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

The “Coming of Age” and Bioterrorism

Perpetrators Availability of biological agents Methods of dissemination

Page 9: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

The Spectrum of Terrorists

State-sponsored Insurgent/rebel Doomsday/cult-type group Non-aligned terrorists Splinter groups Lone offenders

Page 10: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Sources of Agents for Terrorism Use

World Directory of Collections of Cultures and Microorganisms 453 worldwide repositories in 67 nations 54 ship/sell anthrax 18 ship/sell plague

International black-market sales associated with governmental programs

Page 11: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Methods of Dissemination of Biologic Agents

Postal service: never previously reported Aerosol

Enclosed areas Community-wide

Ingestion Mass produced food Water supplies

Page 12: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

“You have to be lucky all the time. We have to be lucky just once!”

– Irish Republican Army

Page 13: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

“The only difference between reality and fiction is that fiction has to make sense.”

– Tom Clancy

Page 14: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Syndromes Suggesting BT

Encephalitis Hemorrhagic mediastinitis Pneumonia with abnormal liver function Papulopustular rash Hemorrhagic fever Descending paralysis Nausea, vomiting +/- diarrhea

Page 15: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 16: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Biological Terrorism: Likely Agents

Bacterial: Anthrax Q fever Brucellosis Tularemia Plague

Viral: SmallpoxViral encephalitidesViral hemorrhagic fever

Toxin: BotulismRicin Staph, Enterotoxin B

Page 17: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Ideal Characteristics for Potential Biological Terrorism Agent

Inexpensive and easy to produce Can be aerosolized (1-10µm) Survives sunlight, drying, heat Cause lethal or disabling disease Person-to-person transmission No effective treatment or prophylaxis

Page 18: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 19: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Anthrax

Caused by Bacillus anthracis, a rod shaped, sporulating organism

Is a zoonotic disease in cattle, sheep, and horses

Transmission through scratches or abrasions of skin, wounds, eating insufficiently cooked infected meat, or inhalation of spores

Page 20: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Dixon, T. C. et al. N Engl J Med 1999;341:815-826

Pathophysiology of Anthrax

Page 21: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Dixon, T. C. et al. N Engl J Med 1999;341:815-826

Cutaneous Anthrax Infection of the Hand and Cheek

Page 22: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Anthrax (cont.)

Case fatality in untreated inhalational disease is almost 100% In recent 2001 occurrence, “only” 3/6 died

Incubation 1 – 45 days, most within 21 days Initial flu-like symptoms are often followed by

abrupt development of severe respiratory distress, shock, and death within 24 hours

Page 23: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                                    

Page 24: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 25: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Bush, L. M. et al. N Engl J Med 2001;345:1607-1610

Anteroposterior Chest Radiograph Obtained on Admission, Showing the Widened Mediastinum That Is Characteristic of Anthrax

Page 26: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Bush, L. M. et al. N Engl J Med 2001;345:1607-1610

Cerebrospinal Fluid Specimen Containing Many Polymorphonuclear White Cells and Gram-Positive Bacilli (Gram's Stain, x1000)

Page 27: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Dixon, T. C. et al. N Engl J Med 1999;341:815-826

Differential Diagnosis of Clinical Manifestations of Anthrax

Page 28: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Anthrax (cont.)

Medical management must be reserved for those with early symptoms or no symptoms

Use of antibiotics for treatment (penicillin, ciprofloxacin, or IV doxycycline) and prophylaxis and vaccination

No secondary transmission

Page 29: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 30: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Swartz, M. N. N Engl J Med 2001;345:1621-1626

Recommendations for Postexposure Prophylaxis

Page 31: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Swartz, M. N. N Engl J Med 2001;345:1621-1626

Recommendations for Antimicrobial Therapy of Clinical Inhalational Anthrax

Page 32: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Anthrax (cont.)

Weaponized by the U.S. in 1950s and 60s Major emphasis of USSR program Can be delivered as aerosol

Page 33: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 34: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 35: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Incubation-Days

0-67-1314-2021-2728-44

Cases*

62896

11

Died

625765

Days to Death

4.52.53.04.53.5

* 15 additional cases without an exact date of onset; all died.

Inhalational AnthraxSverdlovsk, USSR, 1979

Page 36: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 37: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 38: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Shopping Mall Scenario - Denver

Anthrax aerosolized into shopping mall ventilation system; 10,000 people are present and 9,000 people are exposed; terrorist announces attack at 24 hours.

90% of exposed started on antibiotics by end of day 2, 10% cannot be found initially

Total number hospitalized: 4,950; total requiring ICU care: 2,925; total deaths: 855; total ventilators required: 2601

Page 39: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Shopping Mall Scenario – Denver (cont.)

The 13,000 military beds deployed for the Persian Gulf War would STILL not provide enough ICU beds (approximately 1,300)

Even a small biological terrorism event completely overwhelms a city’s medical care resources

Page 40: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Smallpox

An even worse scenario

Page 41: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Smallpox

Killed more than 500 million persons in the 20th century despite being eradicated in 1978

Mortality of 30% in susceptible population Incubation period of 8 to 16 days

Page 42: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Smallpox (cont.)

Clinical manifestations begin acutely with fever, rigors, vomiting, headache and backache

Approximately 10% of light-skinned patients exhibit erythematous rash during early phase

Two to three days later, an enanthem appears on face, hands, and forearms

Page 43: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Smallpox (cont.)

Transmission begins with rash and lasts throughout convalescence

Ongoing transmission is critical factor Most in the world are no longer protected

by vaccination Currently vaccine and treatment limited

Page 44: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 45: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 46: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 47: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 48: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

January February

4

3

2

1

Case

s

13 15 17 19 21 23 25 27 29 31 2 4 6 8 10 12 14 16 18

Hospital Stay Case 1

Date of Onset of Smallpox Cases by Two-Day IntervalsMeschede Hospital, 1970

Page 49: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.
Page 50: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Plague

Not as likely but of concern

Page 51: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 52: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                       

Page 53: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                                    

Page 54: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                               

                     

Page 55: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Botulism

Page 56: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                        

Page 57: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                                     

Page 58: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

                                                                                              

       

Page 59: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Challenges in Recognizinga Bioterrorism Attack

Biologic agents with delayed onset Medical community is unfamiliar with

many of these diseases Current surveillance system may not be

adequate to detect attack

Page 60: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Epidemiological Clues to BT Event

Uncommon illness in epidemic form Explosive point source epidemic curve Unexplained high mortality Discordant attack rate: outdoor>indoor Sentinel illness – even one case of

anthrax or smallpox

Page 61: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Syndromes Suggesting BT

Encephalitis Hemorrhagic mediastinitis Pneumonia with abnormal liver function Papulopustular rash Hemorrhagic fever Descending paralysis Nausea, vomiting +/- diarrhea

Page 62: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Ten CommandmentsSummary

1. Index of Suspicion2. Protect Thyself and Thy

Patients3. Assess the Patient 4. Decontaminate 5. Diagnosis6. Treatment7. Infection Control8. Alert 9. Epidemiologic Assessment10. Spread the Gospel

Page 63: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Response Planning

Federal government State and local government Healthcare systems Media Infrastructure support

Page 64: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Impact on Healthcare System

Potential for widespread illness, in unprecedented numbers

Limited therapeutic stockpiles Need special protective measures for

medical care, clinical lab, and autopsy Panic/terror among the ill, the exposed,

and healthcare providers

Page 65: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Other Critical Issues

Legal aspects Criminal investigation Controlling civil disorder Quarantine

Continued public health activities

Page 66: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

Planning Responses to Biological Terrorism

Are we ready? Should we get ready? Is it possible to be effectively prepared?

Page 67: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

It’s not a matter of “if,” but when, which agent,

and how bad it will be!

Page 68: BIOLOGICAL TERRORISM Edward L. Goodman, MD, Chief of Infectious Diseases Presbyterian Hospital of Dallas December 14, 2005.

World Trade Center